Newmark targets $630M adjusted EBITDA by 2026 amid growth in market share and business lines
Q4 2024 Management View Barry Gosin, CEO, highlighted double-digit top-line growth across all major business lines, with management and servicing revenue up 21%, capital markets up 20%, and leasing up ...
Applied DNA Sciences fails to secure quorum at meeting
STONY BROOK, NY - Applied DNA Sciences Inc . (NASDAQ:APDN), a company specializing in testing laboratories currently trading at $0.17 per share with a market capitalization of $8.89 million, reported ...
Dare Bioscience risks Nasdaq delisting over market value
SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...
Hosted on MSN1h
Global Star Acquisition Inc. Faces Nasdaq Delisting
Global Star Acquisition Inc. (NASDAQ:GLST), a blank check company with a market capitalization of $40.38 million and current stock price of $11.31, has submitted an appeal to Nasdaq after receiving a ...
Solidion Technology Inc. secures top talent with new agreements
Solidion Technology Inc. (NASDAQ:STI), a Dallas-based manufacturer specializing in miscellaneous electrical machinery, equipment, and supplies, has finalized employment agreements with key executive ...
Zacks Investment Research on MSN1h
Bumble Inc. (BMBL) Advances While Market Declines: Some Information for Investors
In the latest trading session, Bumble Inc. (BMBL) closed at $8.46, marking a +0.71% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.01% for the day. Meanwhile, ...
DevvStream Corp. faces Nasdaq delisting over share price
DevvStream Corp., a company listed under the investors sector with a market capitalization of $12.73 million, has been notified by The Nasdaq Stock Market LLC of a potential delisting due to its share ...
Neurocrine Biosciences chief commercial officer sells $251,426 in stock
Eric Benevich, the Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), recently disclosed significant stock transactions. According to a Form 4 filing with the Securities and ...
Zacks Investment Research on MSN1h
Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $60.30, moving +1.88% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.01%. On ...
Oncolytics Biotech faces Nasdaq delisting over share price
SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
Why DaVita Inc Stock Is Plummeting Today
Shares of DaVita Inc (NYSE: DVA) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day. The drop comes as the S&P 500 lost 0.1%, ...